Human glucocorticoid receptor 1A promoter and splice variants
AssigneeBoard of Supervisors of Louisiana State University and Agricultural and Mechanical College
InventorsWayne V. Vedeckis, Mary B. Breslin
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoard of Supervisors of Louisiana State University and Agricultural and Mechanical College
InventorsWayne V. Vedeckis, Mary B. Breslin
Estimating the term…
A new sequence, hGR 1Ap/e, has been isolated from human DNA upstream from the previously known 2.7 kbp human GR promoter region. This new sequence was found to contain a new promoter (the 1A GR promoter) and a new untranslated exon sequence (GR exon 1A) for the human glucocorticoid receptor protein (hGR). Alternative splicing produces three different hGR 1A-containing transcripts, 1A1, 1A2, and 1A3. Exon 1A3-containing GR transcripts appear to be restricted to blood cell cancers and to the human brain. Glucocorticoid hormone treatment caused an up-regulation of exon 1A3-containing GR transcripts in T-lymphoblast cells, and a down-regulation of exon 1A3-containing transcripts in B-lymphoblast cells. Thus detection of exon 1A3-containing transcripts can be used for the diagnosis of patients with blood cell cancers, including T-cell acute lymphoblastic leukemia (ALL), and to identify patients that would benefit from glucocorticoid hormone treatment.
A method to detect the presence of cancerous lymphocytes in a human, said method comprising the steps of:
A method to determine the responsiveness of a patient with cancerous lymphocytes to future treatment with glucocorticoids, said method comprising the steps of:
Dependencies are inferred from the claim text.